Login / Signup

Linear IgA bullous dermatosis and elevated bullous interleukin-6 levels: Responsive to treatment with Anti-IL-6 receptor monoclonals.

Stanley C JordanBonnie BalzerCynthia NastJanet AtienzaKatherine LimSanjeev KumarNicholas NissenBongha Shin
Published in: Clinical case reports (2023)
Linear IgA bullous dermatosis (LABD) is  a rare autoimmune/inflammatory skin condition. Here, we report on a patient who developed treatment resistant LABD. At diagnosis, elevations of IL-6 and C-reactive protein in the blood and extreme elevations of IL-6 in LABD bullous fluid were seen. The patient responded well to tocilizumab (anti-IL-6 receptor) treatment.
Keyphrases
  • case report
  • rheumatoid arthritis
  • oxidative stress
  • combination therapy
  • juvenile idiopathic arthritis
  • soft tissue
  • wound healing
  • drug induced
  • neural network
  • smoking cessation